SV Investment Corp is a Korea-based venture capital (VC) firm principally engaged in the investment in small to medium enterprises (SMEs). The Company principally engaged in the investment in SMEs and venture companies, overseas investment, establishment and management of business incubation centers, as well as formation of private equity funds (PEF). In addition, the Company also provides initial public offering (IPO), merger and acquisitions (M&A), and secondary support services.

Employees

Sector

Investment Management & Fund Operators

More about the company

Quotes

Date	Price	Change	Volume
23/09/26	₩2,725.00	+2.06%	546,407
22/09/26	₩2,670.00	-0.74%	1,322,201
21/09/26	₩2,690.00	-0.37%	1,776,148
18/09/26	₩2,700.00	+1.69%	2,508,873
17/09/26	₩2,655.00	+5.57%	12,090,757

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 23/09/2026			5-day change	1st Jan Change
2,725.00 ^KRW	+2.06%		+0.93%	+59.26%

09-01	Incerasolution Co., Ltd. announced that it has received KRW 13.5 billion in funding from a group of investors	CI
08-19	KaliVir Immunotherapeutics, Inc. announced that it has received $25 million in funding from Premier Partners, LLC, Quad Investment Management Corp., Nextrans, Flexus Partners Co., Ltd., SV Investment Corporation, Company K Partners Limited	CI

Market Cap	164B 121M 106M 100M 91.18M 171M 11.57B 172M 1.2B 464M 5.91B 453M 443M 19B	P/E 2025	-13.1x	P/E 2026	-205x
Enterprise Value	171B 126M 111M 104M 95.17M 178M 12.08B 179M 1.25B 484M 6.17B 473M 463M 19.83B	EV / Sales 2025	3.42x	EV / Sales 2026	10.4x
Free-Float	75.22%	Yield 2025 *	-	Yield 2026	-

09-01	Incerasolution Co., Ltd. announced that it has received KRW 13.5 billion in funding from a group of investors	CI
08-19	KaliVir Immunotherapeutics, Inc. announced that it has received $25 million in funding from Premier Partners, LLC, Quad Investment Management Corp., Nextrans, Flexus Partners Co., Ltd., SV Investment Corporation, Company K Partners Limited	CI
08-13	SV Investment Corporation Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
07-02	LinqAlpha Inc. announced that it has received $21.99996 million in funding from a group of investors	CI
06-18	SV Investment Corporation Reports Earnings Results for the Full Year Ended March 31, 2026	CI
05-29	XCENA Inc. announced that it has received KRW 202 billion in funding from a group of investors	CI
05-28	ASTEROMORPH announced that it has received KRW 47 billion in funding from a group of investors	CI
05-21	LinqAlpha Inc. announced that it expects to receive $19.999992 million in funding	CI
05-14	SV Investment Corporation announces Annual dividend, payable on July 16, 2026	CI
04-14	XCENA Inc. announced that it expects to receive KRW 150 billion in funding from a group of investors	CI
02-25	GenEdit Inc. announced that it has received $60 million in funding from a group of investors	CI
02-13	SV Investment Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11-14	SV Investment Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI

1 day	+2.06%
1 week	+0.93%
Current month	+17.46%
1 month	+9.66%
3 months	+35.57%
6 months	-24.62%
Current year	+59.26%

SV Investment Corporation Stock

Stocks

A289080

KR7289080004

Investment Management & Fund Operators

Valuation: SV Investment Corporation

Chart: SV Investment Corporation

Latest news: SV Investment Corporation

Quotes and Performance

Price Extremes

Managers and Directors: SV Investment Corporation

Venture Capital

Financials

Company Profile

Quotes

1 week	2,655	2,830
1 month	2,200	2,910
Current year	1,439	5,030
1 year	1,439	5,030
3 years	1,156	5,030
5 years	1,156	5,030
10 years	1,156	8,570

Manager	Title	Age	Since
Won-Ho Hong CEO	Chief Executive Officer	61	30/09/2019
Seong-Ho Park CEO	Chief Executive Officer	57	-
Ji-Hwa Ryu PRN	Corporate Officer/Principal	56	30/06/2023

Director	Title	Age	Since
Seong-Ho Park BRD	Director/Board Member	57	-
Won-Ho Hong BRD	Director/Board Member	61	30/09/2019
Ji-Hwa Ryu BRD	Director/Board Member	56	30/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SV INVESTMENT CORPORATION	+2.06%	+0.93%	+42.74%	+49.48%	121M
BB BIOTECH AG	-0.20%	-2.29%	+41.75%	+22.25%	3.4B
HERCULES CAPITAL, INC.	+1.01%	-2.08%	-11.15%	+2.66%	3.13B
HBM HEALTHCARE INVESTMENTS AG	+0.88%	-3.36%	+29.94%	+32.18%	1.84B
MOLTEN VENTURES PLC	+1.21%	-0.15%	+87.60%	+199.33%	1.4B
OCTOPUS APOLLO VCT PLC	0.00%	0.00%	-1.72%	-7.02%	713M
MIRAE ASSET VENTURE INVESTMENT CO., LTD.	+2.95%	+0.85%	+116.14%	+267.22%	697M
BRITISH SMALLER COMPANIES VCT PLC	0.00%	0.00%	-3.97%	-7.05%	401M
OCTOPUS TITAN VCT PLC	+5.71%	+5.71%	-24.49%	-71.54%	404M
PEMBROKE VCT PLC	0.00%	0.00%	-0.53%	-13.02%	362M
Average	+1.36%	+0.47%	+27.63%	+47.45%	1.25B
Weighted average by Cap.	+0.83%	-1.21%	+28.72%	+45.99%

	2025	2026
Net sales	19.98B 14.72M 12.92M 12.2M 11.12M 20.81M 1.41B 20.96M 146M 56.55M 721M 55.27M 54.08M 2.32B	20.52B 15.11M 13.26M 12.53M 11.42M 21.37M 1.45B 21.52M 150M 58.06M 740M 56.75M 55.52M 2.38B
Net income	-5.23B -3.85M -3.38M -3.19M -2.91M -5.45M -369M -5.49M -38.23M -14.81M -189M -14.47M -14.16M -607M	-1B -738K -647K -611K -557K -1.04M -70.69M -1.05M -7.31M -2.83M -36.11M -2.77M -2.71M -116M
Net Debt	-1.04B -767K -673K -635K -579K -1.08M -73.49M -1.09M -7.6M -2.95M -37.54M -2.88M -2.82M -121M	7.18B 5.29M 4.64M 4.38M 3.99M 7.48M 507M 7.53M 52.45M 20.31M 259M 19.86M 19.43M 832M